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SHORT REPORTS
Study of possible risk factors for
severe retinopathy in non-insulin
dependent diabetes
Diabetic retinopathy is one of the commonest causes of visual loss
in Britain.' Various factors have been reported to be associated with
retinopathy, but few studies have looked at these in relation to
aetiological type of diabetes or severity of complications. We report
a study of possible risk factors for severe retinopathy in a group of
non-insulin dependent diabetics selected from our clinic.
Patients, methods, and results
We selected consecutively from the clinic 100 non-insulin dependent
diabetics. Fifty had severe retinopathy (proliferative retinopathy or maculo-
pathy) that had developed within 10 years of diagnosis (group 1), and 50
had no evidence of microvascular complications after more than 14 years of
diabetes (group 2). Non-insulin dependent diabetes was diagnosed if patients
developed diabetes in middle or late life without ketosis. Groups were
compared with respect to sex, cigarette smoking, blood pressure, serum
creatinine concentration, family history, treatment regimens, and glycaemic
control. Blood pressure was measured by the same observer after three
minutes' recumbency. Diastolic pressure was recorded as fifth phase (fourth
phase if no clear end point). Glycaemic control was assessed as mean
laboratory blood glucose value over the previous five years, most subjects
having had a mid-morning and afternoon measurement before each clinic
visit. Results were analysed by a Wilcoxon U or y2 test.
Mean clinic blood glucose values and current treatment regimens in groups I
and 2*
Group 1 Group 2
Mean (SEM) blood glucose (mmol/1) 8-8 (0 4) 8 9 (0-3)
Treatment required:
Diet alone 3 4
Sulphonylurea Half of maximum dose 25 18Half of maximum dose 13 21
Insulin 9 7
There were no significant differences in mean clinic blood glucose measurements
over previous five years or in current treatment regimens.
Coniversionz: SI to traditionial i,,zits-Glucose: 1 mmol/ll 18 mg/100 ml.
There were no significant differences in mean age (63 SEM 1) v 62 (0 9)
years) or percentage of ideal body weight (124 (SEM 4) v 120 (5)) between
groups 1 and 2. Duration of diabetes was longer in group 2 (18 (SEM 0 7)
years, range 15-34, v 10 (0 8) years, range 1-22). Mean blood pressure was
significantly greater in group 1 than in group 2 (systolic 172 (SEM 5) v 142
(3) mm Hg, and diastolic 93 (2) v 80 (2) mm Hg; p< 0001). Twenty two
subjects in group 1 and two in group 2 were receiving antihypertensive
agents (p < 0-001). In group 1 six subjects had persistent proteinuria of whom
five had a raised serum creatinine concentration (range 130-200 ,tmol/l; 1-5-
2-3 mg/l00 ml). There were significantly more women in group 1 than in
group 2 (31/50 v 21/50; p< 0 05). There were no significant differences in
frequency of first degree family history of diabetes (20 in group 1 v 25 in
group 2) or cigarette smoking (eight current and four previous smokers in
past five years in group 1; 11 and 5 respectively in group 2). Mean clinic
blood glucose concentrations over the previous five years were similar, as
were the treatment regimens (table). Eleven subjects in group 1 and six in
group 2 had coincident coronary artery, cerebrovascular, or peripheral
vascular disease.
Comment
In this study hypertension, and to a less extent female sex, was
most strongly associated with severe retinopathy in non-insulin de-
pendent diabetes. No significant associations were found with cigarette
smoking, family history, body weight, or diabetic control. An asso-
ciation between hypertension and retinopathy has been reported in
insulin dependent diabetics2 and Pima Indians,3 but other reports
have not separated patients into aetiological types or according to
severity of complications.' 4 It has been suggested that the association
might be related to coincident renal disease, but in our study only five
subjects had renal impairment. An excess of female patients with
retinopathy has been reported5 and may simply reflect the greater
frequency of non-insulin dependent diabetes in women, but this
would not explain why men predominated in our uncomplicated
group. Surprisingly, glycaemic control and treatment regimens were
similar in the two groups, but this may reflect our imperfect assess-
ment of glycaemic control. Possibly poor control before complications
develop is more important in the pathogenesis of microangiopathy.
We conclude that of the possible risk factors examined in patients
with non-insulin dependent diabetes, hypertension was most closely
associated with severe retinopathy.
Keen H. Prevalence of blindness in diabetics. J R Coll Physicians Lond
1972 ;7 :53-60.
2 Bodansky HJ, Cudworth AG, Drury PL, Kohner EM. Risk factors
associated with severe proliferative retinopathy in insulin-dependent
diabetes mellitus. Diabetes Care 1982 ;5 :97-100.
3Knowler WC, Bennett PH, Ballintine EJ. Increased incidence of retino-
pathy in diabetics with elevated blood pressure. N Engl J Med 1980;
302:645-50.
4Job D, Tchobroutsky G, Eschwege E, et al. Relationship between diabetic
retinopathy, blood pressure, body weight and serum lipid levels.
Diabetologia 1973 ;9 :74.
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Pneumococcal bacteraemia in
mother and son
Epidemics of pneumococcal infection have been described in certain
crowded communities' 2'but in most British homes the risk of catching
pneumococcal pneumonia from an affected relative is generally
regarded as small.3 No special precautions are taken against cross
infection, although the mortality from pneumococcal pneumonia
(especially when accompanied by bacteraemia) is high.4 We describe
the case of a mother with pneumonia and bacteraemia caused by
Streptococcus pneumoniae type 1 who transmitted the disease to her
son. The mother was admitted to hospital first and the son, though ill,
did not seek medical attention.
Case histories
Case 1-A 69 year old woman with chronic bronchitis was admitted to this
hospital with a two day history of increasing dyspnoea, left sided pleuritic
pain, and non-productive cough. She was confused, tachypnoeic, feverish
(38°C), centrally cyanosed, and had signs of pulmonary consolidation at the
left base. A chest radiograph confirmed collapse of the lower lobe and consoli-
dation. Blood was obtained for culture but no sputum could be produced.
Treatment was instituted with 500 mg ampicillin and 500 mg cloxacillin
intravenously four times a day and general supportive measures. S pneumoniae
capsular type 1 was isolated from the blood culture after overnight incubation.
Treatment was changed to benzylpenicillin 2 mU six hourly. She had a very
stormy course requiring monitored low dose oxygen for hypoxia, hypercapnia,
and transient collapse of the whole left lung and was discharged on the 18th
day. Two days after admission relatives had sought advice about her son,
who lived in the same two bedroomed house. He had similar symptoms but
did not wish to see a doctor. The general practitioner was alerted and on
visiting confirmed that the son required urgent admission to hospital.
Case 2-The 32 year old son presented with a history of severe dyspnoea
and pleuritic chest pain on the right. Since his mother's admission four days
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previously he had felt generally unwell and had experienced rigors the day
before admission. He had a history of asthma but was not taking regular
medication and had never been given corticosteroids. He was feverish (38-6°C)
and the radiograph showed a dense area of consolidation in the right upper
lobe. Sputum and blood were obtained for culture and treatment begun with
benzylpenicillin. The fever resolved within 24 hours of starting treatment and
he recovered uneventfully. S pneumoniae capsular type 1 was isolated from the
blood culture after overnight incubation. Sputum culture yielded mouth
commensals only.
Comment
We suggest that a good prospective study of pneumococcal pneu-
monia is needed to establish whether transmission is common,
especially where contacts have a history of underlying lung disease or
other predisposing factors.5 The high mortality from this condition
should not be forgotten and the importance of obtaining blood cultures
as well as sputum culture from patients with a clinical diagnosis of
pneumonia cannot be overemphasised.
We thank Dr P Howard and Dr J D Ward for permission to report their
cases, and Mr R Howden for typing the pneumococcal isolates.
MacLeod CM, Hodges RG, Heidelberger M, Bernhard WG. Prevention of
pneumococcal pneumonia by immunisation with specific capsular
polysaccharides. J Exp Med 1945;82:445-65.
2 Austrian R. Prevention of pneumococcal infection by immunization with
capsular polysaccharides of streptococcus pneumoniae: current status
of polyvalent vaccines. J Infect Dis 1977;136, suppl:838-42.
' Austrian R, Bennett IL. Pneumococcal infections. In: Harrison's principles
of internal medicine. New York: McGraw-Hill Book Co, 1974:766-72.
'Austrian R. Pneumococcal infection and pneumococcal vaccine. N Engl J
Med 1977;297 :938-9.
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Relative palatability of liquid
enteral feeds for general hospital
patients: simple method of
assessment
Many hospital patients need oral supplements to improve their daily
intake of nutrients. Successful use of such supplements requires them
to be sufficiently acceptable for reasonable volumes to be consumed
regularly. Although manufacturers make claims for the palatability
of their products, this subject has received little scientific attention,
although some studies have been conducted specifically on patients
with cancer.'
Subjects, methods, and results
We undertook this study to compare the acceptability of six commercially
available products widely used in hospitals in the United Kingdom and
comparable in composition. The products chosen were Build Up (Carnation
Foods), Clinifeed 400 (Roussel Laboratories), Complan (Farley Health
Products), Ensure (Abbott Laboratories), Isocal (Mead Johnson), and
Nutrauxil (Kabi Vitrum). The vanilla flavour of each product was used,
Complan being flavoured with vanilla essence.
A randomised double blind taste testing technique was used. Subjects
were offered in random order 10 ml samples of each product in identical
containers labelled with random double digits. They were asked to rate the
palatability of each product on a five point scale ranging from "like definitely"
to "dislike definitely." Between tastings the palate was cleared with water
and a plain water biscuit. The study comprised 47 patients (24 women and
23 men, mean age 55-6 years) from general surgical wards, all eating a normal
hospital diet, and 48 controls (24 women and 24 men, mean age 32-5 years)
The table shows the results, which were ranked and analysed using the x2
test. Admission to hospital appeared to influence assessment of palatability
since hospital patients registered fewer overall "dislike" responses (330' v
520%) and more "like" responses (54%e v 33%O) than controls (p .0 05).
A reproducibility study was undertaken on a separate group of 15 patients
(five women and 10 men, mean age 57-2 years) to check the reliability of the
method, the patients performing the test on two occasions one week apart.
The results were analysed with Spearman's rank correlation and confirmed
reproducibility, particularly for three of the products-namely, Build Up,
Ensure, and Isocal.
Comment
The differences between patient and control responses may be
accounted for by an anxiety to please or more acceptance of unusual
substances by hospital patients, although certain diseases such as
cancer change taste perception.'-3 Despite these differences Build Up
was clearly the product most acceptable to patients and controls, and
should, therefore, be the supplement of choice. This preference may
have been due to its more natural taste as it is reconstituted with fresh
milk. The cost per gram nitrogen is considerably lower than that of
other products tested except Complan. A practical drawback to its
use is the extra time taken in preparation. Build Up has a fairly low
ratio of energy to nitrogen, which could be increased by adding an
energy source such as Caloreen. As Isocal was consistently the least
acceptable product we recommend that it is not used as an oral
supplement despite being comparable in price and composition. As
the four other products are all similar in composition and accept-
ability we suggest that the cheapest is used.
The method used in this study is simple to perform and, under
the controlled conditions described would be a useful test for assessing
other products.
De Wys WD, Hillenbrand Herbst S. Oral feeding in the nutritional
management of the cancer patient. Cancer Res 1977;37:2429-31.
2 Hall JC, Staniland JR, Giles GR. Altered taste thresholds in gastro-
intestinal cancer. Clin Oncol 1980;6:137-42.
3Williams LR, Cohen MH. Altered taste thresholds in lung cancer. Am J
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Palatability offood supplements (figtres are numbers of responses)
Liked definitely Liked mildly Neither liked nor disliked Disliked mildly Disliked definitely
Product
Controls Patients Controls Patients Controls Patients Controls Patients Controls Patients
Build Up 13 24 14 15 7 3 6 - 8 5
Clinifeed 6 5 13 21 8 8 13 3 8 10
Complan 3 9 6 11 14 10 14 4 11 13
Ensure 10 20 10 7 3 4 12 8 13 8
Isocal 0 10 2 4 6 5 12 5 28 23
Nutrauxil 6 14 11 12 7 7 12 7 12 7
Ranking when subjects were asked which product they liked best:
Controls: Build Up>Ensure>Clinifeed>Nutrauxil>Complan>Isocal (Build Up v Clinifeed p.0 05, Nutrauxil v Isocal p.O0O001, all others NS).
Patients: Build Up>Ensure>Nutrauxil, Clinifeed>Complan> Isocal (Build Up v Ensure p<0 01, Nutrauxil and Clinifeed v Isocal p.0-05, all others NS).
Ranking when subjects were asked to avoid those products they most disliked:
Controls: Clinifeed > Build Up> Nutrauxil > Complan> Ensure> Isocal (Ensure v Isocal p <0001, all others NS).
Patients: Build UP > Nutrauxil > Ensure > Clinifeed > Complan > Isocal (Build Up v Complan p .0 05, Complan v Isocal p .0 01).
